NCT05016947 2026-01-29Venetoclax Plus Inotuzumab for B-ALLDana-Farber Cancer InstitutePhase 1 Active not recruiting23 enrolled
NCT03114865 2025-05-22A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission MaintenanceSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1/2 Active not recruiting44 enrolled